EAM Global Investors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50,206
Closed -$5.05M 44
2025
Q2
$5.05M Sell
50,206
-11,302
-18% -$864K 1.31% 34
2025
Q1
$4.69M Buy
61,508
+19
+0% +$1.45K 1.28% 31
2024
Q4
$4.25M Sell
61,489
-33,353
-35% -$2.4M 0.76% 75
2024
Q3
$6.92M Buy
94,842
+450
+0.5% +$33.2K 1.4% 10
2024
Q2
$6.32M Buy
+94,392
New +$3.66M 1.42% 13

Other funds holding INSM

EAM Global Investors's INSM Position: Q3 2025 in Review

EAM Global Investors sold out of Insmed (INSM) in Q3 2025, closing a stake of 50,206 shares — an estimated $5.05M sold.

EAM Global Investors first reported a position in INSM in Q2 2024 and held it in 5 quarters. The position peaked at $6.92M in Q3 2024. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • EAM Global Investors reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • EAM Global Investors sold 50,206 Insmed shares in Q3 2025, an estimated $5.05M.
  • EAM Global Investors first reported a position in Insmed in Q2 2024 and held it in 5 quarters.
  • EAM Global Investors's Insmed position peaked at $6.92M in Q3 2024.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on EAM Global Investors's 13F filing for Q3 2025, filed 14 Nov 2025.